COVID-19 vaccination was not associated with impaired fertility in either males or females, according to a study funded by the National Institutes of Health (NIH). To examine the association between…
The Food and Drug Administration (FDA) has approved Rinvoq® (upadacitinib) for the treatment of refractory, moderate to severe atopic dermatitis in patients 12 years of age and older whose disease…
The Food and Drug Administration (FDA) has approved Ryaltris (olopatadine hydrochloride, mometasone furoate) nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis in adults and pediatric patients…
The Food and Drug Administration (FDA) has granted Fast Track designation to ATRS-1902 for the treatment of acute adrenal insufficiency in adults and adolescents. ATRS-1902 is an investigational rescue treatment…
In 2022 and beyond, the care of patients with asthma will likely be transformed by novel monoclonal antibodies targeting cytokines, new asthma guidelines emphasizing precision medicine, and real-world evidence on…
High sitting time during the COVID-19 pandemic was associated with depression, according to the results of a study published in Frontiers in Psychiatry. This longitudinal study analyzed data from the…
A review of the literature on meibomian gland health (MG) and contact lens (CL) use shows “conflicting relationships,” and the need for future longitudinal studies with standardized clinical meibomian gland…
Although physicians in the United States were as likely to vote in the 2018 midterm election and more likely to vote in the 2020 presidential election compared with the general…
Off-label use of cardiovascular (CV) drugs in home therapy is common for children with congenital or acquired heart disease, according to a study published in The American Journal of Cardiology.…
The Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to 2 oral antiviral therapies for COVID-19. Concise drug information for molnupiravir and Paxlovid is provided below. Prior…